We are live on ! Find out more
MKA

M. Kulyk & Associates Portfolio holdings

AUM $536M
1-Year Est. Return 18.28%
This Fund
S&P 500
This Quarter Est. Return
-6.87%
1 Year Est. Return
+18.28%
3 Year Est. Return
+52.28%
5 Year Est. Return
+66.13%
10 Year Est. Return
AUM
$288M
AUM Growth
-$33.7M
Cap. Flow
-$8.06M
Cap. Flow %
-2.8%
Top 10 Hldgs %
40.72%
Holding
101
New
8
Increased
43
Reduced
29
Closed
1

Top Buys

Rank Stock Value
1
LEVI icon
Levi Strauss
LEVI
+$21.3M
2
MRK icon
Merck
MRK
+$4.16M
3
LH icon
Labcorp
LH
+$2.52M
4
WSM icon
Williams-Sonoma
WSM
+$2.44M
5
STIP icon
iShares 0-5 Year TIPS Bond ETF
STIP
+$2.26M

Sector Composition

Rank Sector Weight
1 Technology 19.71%
2 Consumer Discretionary 12.54%
3 Healthcare 10.23%
4 Consumer Staples 10.19%
5 Financials 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEPC icon
51
Brookfield Renewable
BEPC
$6.19B
$1.69M 0.59%
51,625
+8,237
+19% +$317K
CEG icon
52
Constellation Energy
CEG
$93.2B
$1.58M 0.55%
19,012
-11,621
-38% -$857K
STAG icon
53
STAG Industrial
STAG
$7.1B
$1.48M 0.51%
52,050
+19,473
+60% +$614K
ESGV icon
54
Vanguard ESG US Stock ETF
ESGV
$13.5B
$1.45M 0.5%
23,050
+143
+0.6% +$10K
STLD icon
55
Steel Dynamics
STLD
$37.5B
$1.3M 0.45%
+18,327
New +$1.39M
IWF icon
56
iShares Russell 1000 Growth ETF
IWF
$127B
$1.05M 0.36%
19,916
DVY icon
57
iShares Select Dividend ETF
DVY
$23.5B
$962K 0.33%
8,971
+1
+0% +$120
MPT
58
Medical Properties Trust
MPT
$2.75B
$852K 0.3%
71,801
+28,750
+67% +$435K
AMP icon
59
Ameriprise Financial
AMP
$49.5B
$736K 0.26%
2,922
PEP icon
60
PepsiCo
PEP
$189B
$695K 0.24%
4,260
-343
-7% -$59.1K
ABBV icon
61
AbbVie
ABBV
$431B
$681K 0.24%
5,072
GOOG icon
62
Alphabet (Google) Class C
GOOG
$4.36T
$677K 0.24%
7,040
TSLA icon
63
Tesla
TSLA
$1.26T
$670K 0.23%
2,525
-40
-2% -$11.2K
AMZN icon
64
Amazon
AMZN
$2.94T
$537K 0.19%
4,749
-311
-6% -$39.3K
KRBN icon
65
KraneShares Global Carbon Strategy ETF
KRBN
$142M
$531K 0.18%
14,272
+526
+4% +$23.2K
JNJ icon
66
Johnson & Johnson
JNJ
$619B
$515K 0.18%
3,154
+10
+0.3% +$1.69K
HEDJ icon
67
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.87B
$500K 0.17%
16,090
+154
+1% +$5.19K
HSY icon
68
Hershey
HSY
$36.8B
$479K 0.17%
2,173
SBUX icon
69
Starbucks
SBUX
$120B
$476K 0.17%
5,653
LOW icon
70
Lowe's Companies
LOW
$122B
$474K 0.16%
2,523
SPTS icon
71
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.11B
$433K 0.15%
14,991
-1,311,020
-99% -$38.4M
ABT icon
72
Abbott
ABT
$187B
$407K 0.14%
4,204
BRK.B icon
73
Berkshire Hathaway Class B
BRK.B
$1.13T
$382K 0.13%
1,430
-7
-0.5% -$1.99K
WAB icon
74
Wabtec
WAB
$49.9B
$376K 0.13%
4,624
-127
-3% -$11.2K
VTI icon
75
Vanguard Morningstar Total Stock Market ETF
VTI
$680B
$375K 0.13%
2,092
-16
-0.8% -$3.19K

Similar funds

M. Kulyk & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, M. Kulyk & Associates held 101 positions worth $288M, down 10% from $321M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

M. Kulyk & Associates's Q3 2022 filing shows 8 new, 43 increased, 29 reduced and 1 closed positions. Its largest new stake was Merck: 46,558 shares worth $4.01M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $38.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • M. Kulyk & Associates's largest Q3 2022 buy was Merck: 46,558 shares worth $4.01M.
  • M. Kulyk & Associates added most to Levi Strauss in Q3 2022, an estimated $21.3M increase.
  • M. Kulyk & Associates's biggest Q3 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $38.4M.
  • M. Kulyk & Associates fully exited Vanguard Dividend Appreciation ETF in Q3 2022, selling an estimated $510K.
  • M. Kulyk & Associates's ten largest holdings make up 41% of its $288M portfolio in Q3 2022.
  • M. Kulyk & Associates opened 8 new positions and closed 1 in Q3 2022.
  • M. Kulyk & Associates's portfolio value fell 10% quarter-over-quarter to $288M.

Based on M. Kulyk & Associates's 13F filing for Q3 2022, filed 7 Nov 2022.